Secondary cancer risk assessment in healthy organs following craniospinal irradiation

References

• Athiyaman H, Mayilvaganan A, Singh D. 2014. A simple planning technique of craniospinal irradiation in the eclipse treatment planning system. J Med Phys. 39(4):251–258. doi:10.4103/0971-6203.144495
   PubMedGoogle Scholar
• Aziz MH, Schneider F, Clausen S, Blank E, Herskind C, Afzal M, Wenz F. 2011. Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays? Radiat Oncol. 6(1):174. doi:10.1186/1748-717X-6-174
   PubMedGoogle Scholar
• Bennett BR, Lamba MA, Elson HR. 2010. Analysis of peripheral doses for base of tongue treatment by linear accelerator and helical TomoTherapy IMRT. J Appl Clin Med Phys. 11(3):3136–3196. doi:10.1120/jacmp.v11i3.3136
   PubMed Web of Science ®Google Scholar
• Bleeker L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, Gijsbers AH, Dubbink HJ, Kros JM, Gijtenbeek JMM, Kurt E, van der Rijt CCD, et al. 2023. Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol. J Neurooncol. 162(1):225–235. doi:10.1007/s11060-023-04285-8
   PubMed Web of Science ®Google Scholar
• Bravim A, Sakuraba RK, Cruz JC, Campos LL. 2015. OSL and TL response characterization of LiF:MG,Ti microdosimeters to be applied to VMAT quality assurance. Appl Radiat Isot. 105:299–302. doi:10.1016/j.apradiso.2015.08.038
   PubMed Web of Science ®Google Scholar
• Cember H, Johnson TE. 2008. Introduction to health physics. 4th ed. New York: McGraw-Hill.
   Google Scholar
• Choi JY. 2023. Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat. 11(1):28–38. doi:10.14791/btrt.2022.0046
   PubMedGoogle Scholar
• Dasher BG, Vann AM. 2006. Portal design in radiation therapy. 2nd ed. California: V&W Enterprises.
   Google Scholar
• De Braganca KC, Packer RJ. 2013. Treatment options for medulloblastoma and CNS primitive neuroectodermal tumor (PNET). Curr Treat Options Neurol. 15(5):593–606. doi:10.1007/s11940-013-0255-4
   PubMed Web of Science ®Google Scholar
• Farace P, Bizzocchi N, Righetto R, Fellin F, Fracchiolla F, Lorentini S, Widesott L, Algranati C, Rombi B, Vennarini S, et al. 2017. Supine craniospinal irradiation in pediatric patients by proton pencil beam scanning. Radiother Oncol. 123(1):112–118. doi:10.1016/j.radonc.2017.02.008
   PubMed Web of Science ®Google Scholar
• Grosshans DR. 2016. Proton therapy for pediatric medulloblastoma. Lancet Oncol. 17(3):258–259. doi:10.1016/S1470-2045(15)00217-X
   PubMed Web of Science ®Google Scholar
• Gurjar OP, Arya R, Goyal H, Handa P, Bagdare P, Khan A, Paliwal RK, Mishra SP. 2019. Craniospinal irradiation in medulloblastoma using high energy medical linear accelerator: an innovative approach to planning technique. J Biomed Phys Eng. 9(2):151–160.
   PubMedGoogle Scholar
• Halperin EC, Wazer DE, Perez CA, Barddy LW. 2019. Perez & Brady’s principles and practice of radiation oncology. 7th ed. Alphen aan den Rijn: Wolters Kluwer.
   Google Scholar
• Khan FM, Gibbons JP. 2014. Khan’s the physics of radiation therapy. 6th ed. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Knežević Ž, Stolarczyk L, Ambrožová I, Caballero-Pacheco MÁ, Davídková M, De Saint-Hubert M, Domingo C, Jeleń K, Kopeć R, Krzempek D, et al. 2022. Out-of-field doses produced by a proton scanning beam inside pediatric anthropomorphic phantoms and their comparison with different photon modalities. Front Oncol. 12:904563. doi:10.3389/fonc.2022.904563
   PubMed Web of Science ®Google Scholar
• Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen II. 2005. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 62(4):1195–1203. doi:10.1016/j.ijrobp.2005.03.053
   PubMed Web of Science ®Google Scholar
• Lee B, Mahmud I, Pokhrel R, Murad R, Yuan M, Stapleton S, Bettegowda C, Jallo G, Eberhart CG, Garrett T, et al. 2022. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs. Acta Neuropathol Commun. 10(1):25. doi:10.1186/s40478-022-01326-7
   PubMed Web of Science ®Google Scholar
• Liuzzi R, Piccolo C, D'Avino V, Clemente S, Oliviero C, Cella L, Pugliese M. 2020. Dose-response of TLD-100 in the dose range useful for hypofractionated radiotherapy. Dose Response. 18(1):1559325819894081. doi:10.1177/1559325819894081
   Web of Science ®Google Scholar
• Majer M, Ambrožová I, Davídková M, De Saint-Hubert M, Kasabašić M, Knežević Ž, Kopeć R, Krzempek D, Krzempek K, Miljanić S, et al. 2022. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: a phantom study. Med Phys. 49(4):2672–2683. doi:10.1002/mp.15493
   PubMed Web of Science ®Google Scholar
• McMahon RL, Larrier NA, Wu QJ. 2011. An image-guided technique for planning and verification of supine craniospinal irradiation. J Appl Clin Med Phys. 12(2):184–190. doi:10.1120/jacmp.v12i2.3310
   Web of Science ®Google Scholar
• Mesbahi A, Seyednejad F, Gasemi-Jangjoo A. 2010. Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study. Jpn J Radiol. 28(5):398–403. doi:10.1007/s11604-010-0432-2
   PubMed Web of Science ®Google Scholar
• Michalski JM, Klein EE, Gerber R. 2002. Method to plan, administer, and verify supine craniospinal irradiation. J Appl Clin Med Phys. 3(4):310–316. doi:10.1120/jacmp.v3i4.2555
   PubMedGoogle Scholar
• Millard NE, De Braganca KC. 2016. Medulloblastoma. J Child Neurol. 31(12):1341–1353. doi:10.1177/0883073815600866
   PubMed Web of Science ®Google Scholar
• Mpumelelo N. 2021. Estimation of effective dose using the dose length product in chest computed tomography procedures. Int J Radiat Res. 19(4):979–986. doi:10.52547/ijrr.19.4.26
   Web of Science ®Google Scholar
• NCRP (National Council on Radiation Protection and Measurements). 1993. Limitation of exposure to ionizing radiation. NCRP report 116. Bethesda (MD): National Council on Radiation Protection and Measurements.
   Google Scholar
• Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, et al. 2009. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 54(8):2277–2291. doi:10.1088/0031-9155/54/8/002
   PubMed Web of Science ®Google Scholar
• NRC (National Research Council). 2006. Health risks from exposure to low levels of ionizing radiation: Beir VII phase II. Washington (DC): National Academy Press.
   Google Scholar
• Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. 2013. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children’s Oncology Group trial A9961. Neuro Oncol. 15(1):97–103. doi:10.1093/neuonc/nos267
   PubMed Web of Science ®Google Scholar
• Parker WA, Freeman CR. 2006. A simple technique for craniospinal radiotherapy in the supine position. Radiother Oncol. 78(2):217–222. doi:10.1016/j.radonc.2005.11.009
   PubMed Web of Science ®Google Scholar
• Rehman J, Tailor RC, Isa M, Afzal M, Chow J, Ibbott GS. 2015. Evaluations of secondary cancer risk in spine radiotherapy using 3DCRT, IMRT, and VMAT: A phantom study. Med Dosim. 40(1):70–75. doi:10.1016/j.meddos.2014.10.003
   PubMed Web of Science ®Google Scholar
• Santos AMC, Kotsanis A, Cunningham L, Penfold SN. 2021. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer. Acta Oncol. 60(3):300–304. doi:10.1080/0284186X.2020.1862421
   PubMed Web of Science ®Google Scholar
• Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD. 2021. Radiotherapy in medulloblastoma-evolution of treatment, current concepts and future perspectives. Cancers (Basel). 13(23):5945. doi:10.3390/cancers13235945
   PubMed Web of Science ®Google Scholar
• Stathakis S, Li J, Ma CCM. 2007. Monte Carlo determination of radiation-induced cancer risks for prostate patients undergoing intensity-modulated radiation therapy. J Appl Clin Med Phys. 8(4):14–27. doi:10.1120/jacmp.v8i4.2685
   PubMed Web of Science ®Google Scholar
• Stokkevåg CH, Engeseth G-M, Ytre-Hauge KS, Röhrich D, Odland OH, Muren LP, Brydøy M, Hysing LB, Szostak A, Palmer MB, et al. 2014. Estimated risk of radiation-induced cancer following pediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol. 53(8):1048–1057. doi:10.3109/0284186X.2014.928420
   PubMed Web of Science ®Google Scholar
• Verma J, Mazloom A, Teh BS, South M, Butler EB, Paulino AC. 2015. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 5(2):93–98. doi:10.1016/j.prro.2014.05.004
   PubMedGoogle Scholar
• Yoon M, Shin DH, Kim J, Kim JW, Kim DW, Park SY, Lee SB, Kim JY, Park HJ, Park BK, et al. 2011. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys. 81(3):637–646. doi:10.1016/j.ijrobp.2010.06.039
   PubMed Web of Science ®Google Scholar
• Young S, Phaterpekar K, Tsang DS, Boldt G, Bauman GS. 2023. Proton radiotherapy for management of medulloblastoma: a systematic review of clinical outcomes. Adv Radiat Oncol. 8(4):101189. doi:10.1016/j.adro.2023.101189
   PubMedGoogle Scholar
• Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD. 2013. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol. 58(4):807–823. doi:10.1088/0031-9155/58/4/807
   PubMed Web of Science ®Google Scholar